COMPANY PROFILE

BRIM Biotechnology

Explore full profile

A clinical-stage company developing novel peptide treatments for hard-to-treat diseases

Taipei, TaiwanFounded 2013Biotech & Life Sciences

Valuation $100–250M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About BRIM Biotechnology

BRIM Biotechnology is a pioneering company in the field of translational science, focusing on the development of innovative peptide-based treatments. The company operates in the biotechnology sector, primarily serving healthcare providers and pharmaceutical companies. BRIM's core business model revolves around identifying high-potential drug candidates and rapidly advancing them to clinical readiness. The company generates revenue through licensing agreements and partnerships with larger pharmaceutical firms. BRIM's lead technology platform is the Pigment Epithelium Derived Factor (PEDF) derived Short Peptide (PDSP), which has shown promise in treating a variety of conditions including dry eye syndrome, corneal wound healing, and osteoarthritis. The company has demonstrated the safety and efficacy of its lead asset, BRM421, in clinical studies, positioning it as a first-in-class treatment for dry eye syndrome. BRIM Biotechnology also focuses on other novel synthetic peptides for severe corneal damage (BRM423) and osteoarthritis (BRM521).

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2013
Headquarters: Taipei, Taiwan
Employees: 19
Open positions: None listed
Dealroom signal: 47.8/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES E✓Equity / VC	Dec 2022	$20M	$80M	Undisclosed	↗
LATE VCEquity / VC	Aug 2022	$18M	$72M	Undisclosed	↗

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

BRIM Biotechnology website traffic

Latest recorded traffic for BRIM Biotechnology is 1K monthly website visits, up 75.4% over the last three months. BRIM Biotechnology's team grew 11.8% over the past year.

Latest monthly visits1K 3-month web change+75.4% 1-year team growth+11.8%

Monthly website visitsNov 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MIMetrodora InstituteA medical and research center dedicated to advancing care and accelerating cures for people living with neuroimmune axis disorders	Salt Lake City, United States	Operational	39	$35M	$140M
TTTay TherapeuticsBiotech platform enhancing patient-specific medicines through advanced discovery and development expertise	Dundee, United Kingdom	Operational
SISPES Pharmaceuticals Inc.The company focuses on the research and development of improved specialty injectable products 505(b)(2)and complex generic drugs	United States	Operational
EXeXmoorIntegrated CDMO partner for cell and gene therapies	Bristol, United Kingdom	Operational
EHEndpoint HealthDelivering new precision therapies to patients	Palo Alto, United States	Closed
GAGalixirOffering pharmaceutical companies with accesses to faster and better drug discovery methods, as well as strong patent protections on drug	Dongcheng District, China	Operational
PBPersephone BiosciencesSynthetic biology company developing a platform to industrialize and scale the microbiome	San Diego, United States	Operational
CHCabinet HealthA sustainable healthcare company, starting with over-the-counter medicine	New York City, United States	Operational